RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
+17.22%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.6B
AUM Growth
+$258M
Cap. Flow
+$1.53M
Cap. Flow %
0.06%
Top 10 Hldgs %
27.05%
Holding
158
New
8
Increased
60
Reduced
23
Closed
11

Top Buys

1
WCG
Wellcare Health Plans, Inc.
WCG
$21.9M
2
UNH icon
UnitedHealth
UNH
$19.6M
3
WST icon
West Pharmaceutical
WST
$15.9M
4
TBIO
Translate Bio, Inc. Common Stock
TBIO
$12.8M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11.2M

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
$41.1M
2
AET
Aetna Inc
AET
$40.4M
3
AVXS
AveXis, Inc. Common Stock
AVXS
$23.5M
4
PRTA icon
Prothena Corp
PRTA
$11.7M
5
PRAH
PRA Health Sciences, Inc.
PRAH
$9.97M

Sector Composition

1 Healthcare 89.32%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALNY icon
51
Alnylam Pharmaceuticals
ALNY
$59.2B
$17.1M 0.66%
173,500
+30,500
+21% +$3M
GLPG icon
52
Galapagos
GLPG
$2.2B
$17.1M 0.66%
185,000
– –
OBSV
53
DELISTED
ObsEva SA Ordinary Shares
OBSV
$17M 0.65%
1,120,000
+280,000
+33% +$4.24M
JAZZ icon
54
Jazz Pharmaceuticals
JAZZ
$7.86B
$16.9M 0.65%
98,000
-25,700
-21% -$4.43M
EPZM
55
DELISTED
Epizyme, Inc
EPZM
$16.8M 0.65%
1,241,253
-33,747
-3% -$457K
BOLD
56
DELISTED
Audentes Therapeutics, Inc
BOLD
$16.8M 0.65%
440,000
-125,000
-22% -$4.78M
ARNA
57
DELISTED
Arena Pharmaceuticals Inc
ARNA
$16.4M 0.63%
375,000
– –
ASND icon
58
Ascendis Pharma
ASND
$12.5B
$16.2M 0.62%
243,500
-40,000
-14% -$2.66M
HOLX icon
59
Hologic
HOLX
$14.8B
$15.9M 0.61%
400,000
– –
WST icon
60
West Pharmaceutical
WST
$18B
$15.9M 0.61%
+160,000
New +$15.9M
BHVN
61
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$15.7M 0.6%
397,500
+72,500
+22% +$2.87M
IDXX icon
62
Idexx Laboratories
IDXX
$51.4B
$15.7M 0.6%
72,000
+9,000
+14% +$1.96M
FOLD icon
63
Amicus Therapeutics
FOLD
$2.46B
$15.6M 0.6%
1,000,000
– –
BIIB icon
64
Biogen
BIIB
$20.6B
$15.4M 0.59%
53,000
– –
RARE icon
65
Ultragenyx Pharmaceutical
RARE
$3.07B
$15.4M 0.59%
200,000
+27,000
+16% +$2.08M
XENT
66
DELISTED
Intersect ENT, Inc
XENT
$15.4M 0.59%
410,000
– –
TBPH icon
67
Theravance Biopharma
TBPH
$703M
$14.8M 0.57%
652,600
– –
GTHX
68
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$13M 0.5%
300,000
+13,000
+5% +$565K
EXEL icon
69
Exelixis
EXEL
$10.2B
$12.8M 0.49%
595,000
+420,000
+240% +$9.04M
TBIO
70
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$12.8M 0.49%
+1,011,079
New +$12.8M
BPMC
71
DELISTED
Blueprint Medicines
BPMC
$12.6M 0.49%
199,000
+41,247
+26% +$2.62M
AMRN
72
Amarin Corp
AMRN
$317M
$12.4M 0.48%
200,000
– –
PTLA
73
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12.2M 0.47%
323,800
– –
IMMU
74
DELISTED
Immunomedics Inc
IMMU
$11.8M 0.46%
500,000
+50,000
+11% +$1.18M
MRTX
75
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.8M 0.46%
240,000
+51,000
+27% +$2.51M
1 2
3
4 5